Bcal Diagnostics Ltd (BDX) — Capital Reinvestment Ratio

Latest as of December 2020: 0.00x

Bcal Diagnostics Ltd (BDX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow (AU$118.98K) in capital expenditures (AU$5.00). Check Bcal Diagnostics Ltd (BDX) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

AU$118.98K

AUD

Capital Expenditures

AU$5.00

AUD

Data as of

Dec 2020

Most recent filing

Annual Capital Reinvestment Ratio for Bcal Diagnostics Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Bcal Diagnostics Ltd from None to None. See free cash flow generation of Bcal Diagnostics Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow